featured case

1

featured case

Saturday, October 16, 2021

central workplaces

read more

3

our technological excellence as a CDMO

We are oncomed – a Contract Development and Manufacturing Organization (CDMO) specialized in aseptic processing of oncology injectables in clinical and commercial scales. We deliver drugs with high potent and cytotoxic characteristics to fight cancer, worldwide.

organic solvents handling

high-potent APIs

single-use systems

sensitive API handling

5 reasons why choose oncomed

5 reasons why choose oncomed

employee skills & mindset

We believe that thanks to our knowledge, flexible approach and endeavour to look for the solution, we may fully support a clients in their needs.

variety of niche technologies

We believe that thanks to our brave approach and state-of-the-art technology, our clients can dare to act with courage too and ask for advanced highly active drug solutions. We (and our technology) will support them.

supply risk mitigation

We understand the cost and time pressures faced by pharmaceutical companies and offer flexible, affordable, and rapid outsourcing services designed to meet specific needs of our customers.

access to free manufacturing capacity

We offer two fully operational lines. We also keep investing into manufacturing capacity and state-of-the-art technologies. Line 3 that will offer highly advanced solutions is in construction.

no additional major investments

We offer various vial formats, variable equipment size and qualified processes. We also take pride in our transparent service offerings that lower any additional investments to a mere minimum.

employee skills & mindset

We believe that thanks to our knowledge, flexible approach and endeavour to look for the solution, we may fully support a clients in their needs.

variety of niche technologies

We believe that thanks to our brave approach and state-of-the-art technology, our clients can dare to act with courage too and ask for advanced highly active drug solutions. We (and our technology) will support them.

supply risk mitigation

We understand the cost and time pressures faced by pharmaceutical companies and offer flexible, affordable, and rapid outsourcing services designed to meet specific needs of our customers.

access to free manufacturing capacity

We offer two fully operational lines. We also keep investing into manufacturing capacity and state-of-the-art technologies. Line 3 that will offer highly advanced solutions is in construction.

no additional major investments

We offer various vial formats, variable equipment size and qualified processes. We also take pride in our transparent service offerings that lower any additional investments to a mere minimum.

upcoming events

CPhI Worldwide 2021

conference meeting

09 Nov – 11 Nov 2021

Milan, Italy

Each year CPhI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the global market.

euroPLX Brussels

conference, partnering

22 Nov – 23 Nov 2021

Brussels, Belgium

The 77th Marketplace is an exchange for licenses, products, assets, distribution deals and other Pharma Business Opportunities ranging from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices.

read our case studies

organic solvents in large volumes

Case study focused on production of organic solvents in large volumes.
read text

deployment of analytical methods from third-country API manufacturers

Case study focused on use of the in-house analytical methods needed for the implementation of alternative APIs.
read text

central workplaces

With the installation of a Line 3 issues related to capacity, robustness, safety, material flow and many others emerged. Now it is not just a project to install a new production line, but a project to modernize our production.
read text